Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Graham Osborn who wrote (56276)	11/25/2015 9:32:09 AM
From: E_K_S	Respond to of 78740

That may/could impact OPK but they have many other tests they do too including a colon cancer test/screen I believe. OPKO Announces Launch of 4Kscore Test for Prostate Cancer OPKO Health Expands Portfolio of Tests for Inherited Forms of Cancer ------------------------------------------------------ Have you heard of Castlight Health, Inc. (CSLT). The company IPO'd in early 2014. They are still burning lots of cash and plan to get cash flow break even in 2017. Castlight Health, Inc. provides cloud-based software in the United States. Its software enables enterprises to understand and manage health care spending. Probably not a value Buy but if/when they get their SG&A in line w/ their revenues, they s/d be able to generate a lot of FCF. I am watching but no position now. I continue to like QSII of the medical software companies but I suspect they may cut their dividend after their recent acquisition. EKS